Tcwp LLC Cybin Inc. Transaction History

Tcwp LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.3 - $0.56 $9,600 - $17,920	-32,000 Reduced 59.04%	22,200 $8,000
Q4 2022 Feb 13, 2023	BUY	$0.26 - $0.64 $1,352 - $3,328	5,200 Added 10.61%	54,200 $16,000
Q3 2022 Nov 14, 2022	SELL	$0.48 - $1.11 $4,800 - $11,100	-10,000 Reduced 16.95%	49,000 $23,000
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.88 $3,894 - $8,360	-9,500 Reduced 13.87%	59,000 $32,000
Q1 2022 May 10, 2022	SELL	$0.74 - $1.22 $25,012 - $41,236	-33,800 Reduced 33.04%	68,500 $55,000
Q4 2021 Jun 13, 2022	BUY	$1.13 - $2.31 $115,598 - $236,313	102,300 New	102,300 $121,000

66.1K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $1.58B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Tcwp LLC, based on Form 13F filings with the SEC.

Stay updated on Tcwp LLC with notifications on news.